This attack does 70 damage for each damage counter on your opponent's Active Pokémon.
Discard an Energy from this Pokémon.
Ascended Heroes was released in 2026. Ascended Heroes is grouped under the Mega Evolution era.
With 295 listed cards, this is a very large set by modern TCG standards. As of this year, it is one of the newest tracked releases.
Galarian Obstagoon (#245) is one of the Illustration Rare prints in this expansion.
In 2026, Ascended Heroes introduced this print of Galarian Obstagoon. Card flavor text reads: "Its voice is staggering in volume.
Obstagoon has a tendency to take on a threatening posture and shout—this move is known as Obstruct." Its card type is Pokémon. The rarity label is Illustration Rare.
Printed HP is 170. Energy typing is Dark.
It carries a Stage 2 subtype designation. Attack line includes "Scarring Shout" and "Punk Smash".
Galarian Obstagoon from Ascended Heroes is currently trading around $4.70. Compared with last week, pricing is 5.7% lower.
It is currently 4.0% below the 30-day average of $4.90. In the past 90 days, observed prices ranged from $4.26 to $12.46 (174% spread), a high-volatility profile.
Rarity classification for this copy is Illustration Rare.
Other Galarian printings create a useful comparison set for Galarian Obstagoon. Comparable entries in this snapshot: 6 cards, 5 distinct sets.
In this sample, pricing ranges between $0.08 and $6.40 (7900% total span). Relative to the alternative average ($2.46), this card is +91%.
Notable alternatives include Galarian Obstagoon #132 (Ascended Heroes) at $0.08, Galarian Obstagoon #SWSH193 (SWSH Black Star Promos) at $3.81, Galarian Obstagoon #SWSH059 (SWSH Black Star Promos) at $1.28, and Galarian Obstagoon #161 (Fusion Strike) at $0.24.
Current valuation lens: Week-over-week movement is negative (5.7%); this leaves value 62% under the 90-day peak. The 90-day range spans $4.26 to $12.46 (174% spread), which indicates high-volatility behavior.
Current value is 4.0% below its 30-day reference ($4.90). Graded context points to a substantial premium curve, with PSA 10 at +2081% above raw pricing.
PSA 10 is currently around $102.52.
